Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter KRT17 Antikörper

Dieses Kaninchen Monoklonal-Antikörper erkennt spezifisch KRT17 in IHC (f). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7126634

Kurzübersicht für Rekombinanter KRT17 Antikörper (ABIN7126634)

Target

Alle KRT17 Antikörper anzeigen
KRT17 (Keratin 17 (KRT17))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 146
  • 54
  • 31
  • 20
  • 15
  • 13
  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 110
  • 49
  • 1
Kaninchen

Klonalität

  • 99
  • 60
  • 1
Monoklonal

Konjugat

  • 77
  • 16
  • 9
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser KRT17 Antikörper ist unkonjugiert

Applikation

  • 120
  • 68
  • 37
  • 34
  • 32
  • 27
  • 26
  • 26
  • 24
  • 16
  • 15
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Spezifität

    Cytokeratin 17 (CK17) is normally expressed in the basal cells ofcomplex epithelia but not in stratified orsimple epithelia. Antibody to CK17 is an excellent tool to distinguish myoepithelial cells from luminal epithelium of various glandssuch as mammary, sweat and salivary. CK17 is expressed in epithelial cells of various origins, such as bronchial epithelial cells and skin appendages. It may be considered as epithelial stem cell marker because CK17 Ab marks basal cell differentiation. CK17 is expressed in SCLC much higher than in LADC. Eighty-five percent of the triple negative breast carcinomas immunoreact with basal cytokeratins including anti-CK17. Also important is that cases of triple negative breast carcinoma with expression of CK17 show an aggressive clinical course. Additionally, anti-CK17 and anti-MUC1 immunoreactivity represents pancreatobiliary subtype whereas anti-MUC2 and anti-CDX-2 positivity defines intestinal subtype.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant full-length human KRT17 protein

    Isotyp

    IgG
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: T24 cells. Humanskin, bladder or cervix.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    KRT17 (Keratin 17 (KRT17))

    Andere Bezeichnung

    KRT17

    Hintergrund

    K17, Keratin Type I Cytoskeletal 17, Keratin-17, KRT17, PCHC1,Cytokeratin 17 (CK17) (Basal Epithelial Marker)
    Cellular localisation: Cytoplasm.

    Molekulargewicht

    46kDa

    Gen-ID

    3872, 2785

    UniProt

    Q04695
Sie sind hier:
Chat with us!